Cannabis Dependence
60
6
7
40
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
23 trials with published results (38%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
3.3%
2 terminated out of 60 trials
95.2%
+8.7% vs benchmark
10%
6 trials in Phase 3/4
57%
23 of 40 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 40 completed trials
Clinical Trials (60)
Neuroimaging of Adolescent Cannabis Use Treatment
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder
Evaluating the Delivery and Effects of THC Vaping Liquids in the Bloodstream
The Neural Correlates of Cannabis Use
Cannabis Abstinence and Neurocognitive Assessment in Adolescence
Exercise Intervention as Treatment for People Using Cannabis (ExIT-C)
Reducing Cannabis Overuse With Prazosin
A Mobile App to Reduce and/or Quit Cannabis Use
Joint Effort 2.0: a Mobile Application With University Students
Varenicline for Co-occurring Cannabis and Tobacco Use
Breathwork-assisted Treatment for Cannabis Use Disorder
Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use
Characterization of the Pattern of Consumption and Withdrawal Syndrome From Dual Cannabis and Tobacco Use
Safety and Efficacy of a FAAH-Inhibitor to Treat Cannabis Withdrawal
Mobile Health for Problematic Behaviors and Substance Use
Cannabis Use and Relapse After One Week of Contingency Management Therapy
Do Adolescents and Adults Differ in Their Acute Response to Cannabis?
Efficacy of Community Reinforcement Approach (CRA) in the Treatment of Cannabis Users
Clinical Trial of N-acetylcysteine Versus Placebo Efficacy in the Cannabis Withdrawal